Abdul Hakkim R, PhD
Co-founder, Chief Operating Officer & Interim CEO
Dr. Hakkim is an immunologist trained at Max Plank Institute and Harvard Medical School. Abdul along with Toby were the first graduate students at the Max Plank to work on the biology and implications of NETs in autoimmunity. At Harvard, Abdul worked on genetics of innate immunity before transitioning into an entrepreneur initially with Genma/Artus a spin-off out of Harvard and now Neutrolis.